ES2311
Model Information:
Squamous cell carcinoma of esophagus, moderately differentiated. Tumor invaded through esophageal wall. Two of nine lymph nodes involved by metastatic carcinoma (2/9). IHC results: CD44(+), CMet(-), COX2(weak +), EGFR(+), ERCC-1(-), HER2(-), Ki-67(+25-50%), P170(-), P27(weak +), P53(+50-75%), TOPOII(+<25%).
| Summary |
|
| Cancer Type |
Esophageal Cancer |
| Grade |
NA |
| Stage |
NA |
| Ethnicity |
Asian |
| Gender |
F |
| Age |
52 |
| Pathology Diagnosis |
Squamous cell carcinoma of esophagus, moderately differentiated. Tumor invaded through esophageal wall. Two of nine lymph nodes involved by metastatic carcinoma (2/9). IHC results: CD44(+), CMet(-), COX2(weak +), EGFR(+), ERCC-1(-), HER2(-), Ki-67(+25-50%), P170(-), P27(weak +), P53(+50-75%), TOPOII(+<25%). |
| Biopsy Site |
Esophagus |
| Treatment History |
NA |
| Pathology QC |
Well to moderately differentiated squamous cell carcinoma (P3) |
| Special Features |
NA |
| Mouse Strain |
Balb/c nu |
| TMA |
TMA-HP-ES-014 |
| Viral Status in PDX |
EBV+ (P4, RNAseq) |
| Available In |
CB_CN |
| RNA Seq |
P4 |
| Exome Seq |
NA |
Growth Characteristics
Additional Characteristics
